272(top 1%)
papers
10.7K(top 1%)
citations
55(top 1%)
h-index
96(top 1%)
g-index
292
all documents
11.6K
doc citations
2.1K
citing journals

Top Articles

#TitleJournalYearCitations
1Inflammation, Growth Factors, and Pulmonary Vascular RemodelingJournal of the American College of Cardiology2009605
2EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitisAnnals of the Rheumatic Diseases2007524
3Mapping and predicting mortality from systemic sclerosisAnnals of the Rheumatic Diseases2017410
4Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care dataBMJ, The2020355
5Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndromeAnnals of the Rheumatic Diseases2007261
6Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitisBlood2008252
7Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren SyndromeJAMA - Journal of the American Medical Association2014241
8Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodiesNature Medicine2022235
9Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)Annals of the Rheumatic Diseases2016225
10Churg–Strauss syndromeCurrent Opinion in Rheumatology2007199
11IgA vasculitis (Henoch–Shönlein purpura) in adults: Diagnostic and therapeutic aspectsAutoimmunity Reviews2015187
12High frequency of venous thromboembolic events in Churg–Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patientsAnnals of the Rheumatic Diseases2009184
13Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysisAnnals of the Rheumatic Diseases2013183
14Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patientsPLoS ONE2017174
15Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*British Journal of Dermatology2022174
16Population‐based prevalence study of Behçet's disease: Differences by ethnic origin and low variation by age at immigrationArthritis and Rheumatism2008170
17Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysisKidney International2006144
18Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Autoimmunity Reviews2017140
19Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitidesAnnals of the Rheumatic Diseases2018139
20Risk factors for major infections in Wegener granulomatosis: analysis of 113 patientsAnnals of the Rheumatic Diseases2009131
21Rationale and efficacy of interleukin-1 targeting in Erdheim–Chester diseaseBlood2010129
22Impact of digital ulcers on disability and health-related quality of life in systemic sclerosisAnnals of the Rheumatic Diseases2010125
23Granulomatous Disease in CVID: Retrospective Analysis of Clinical Characteristics and Treatment Efficacy in a Cohort of 59 PatientsJournal of Clinical Immunology2013125
24Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?Annals of the Rheumatic Diseases2006122
25Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndromeAutoimmunity Reviews2017120
26Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scaleAnnals of the Rheumatic Diseases2007119
27The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover studyThorax2008119
28Characteristics and Management of IgA Vasculitis (Henoch‐Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective SurveyArthritis and Rheumatology2017117
29Adding Azathioprine to Remission‐Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis FactorsArthritis and Rheumatology2017117
30Diversification of human plasmacytoid predendritic cells in response to a single stimulusNature Immunology2018106
31Churg–Strauss syndrome: evidence for disease subtypes?Current Opinion in Rheumatology2010103
32Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcersArthritis Care and Research201194
33A descriptive and prognostic study of systemic sclerosis-associated myopathiesAnnals of the Rheumatic Diseases200987
34Azacitidine for patients with Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registryBritish Journal of Haematology202285
35Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)Neuromuscular Disorders200684
36Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patientsAnnals of the Rheumatic Diseases200781
372020 international consensus on ANCA testing beyond systemic vasculitisAutoimmunity Reviews202079
38A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell ArteritisAmerican Journal of Human Genetics201778
39Suppression of Ectopic Adrenocorticotropin Secretion by the Long-Acting Somatostatin Analog Octreotide*Journal of Clinical Endocrinology and Metabolism198977
40Systemic Sclerosis‐Associated MyopathyAnnals of the New York Academy of Sciences200777
41Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literatureJournal of Autoimmunity201576
42Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic PolyangiitisJournal of Rheumatology201275
43Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO RegistryAnnals of the Rheumatic Diseases201672
44Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasiaAutoimmunity Reviews200571
45Peripheral neuropathy in systemic vasculitidesCurrent Opinion in Rheumatology200570
46Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patientsAutoimmunity Reviews201469
47Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapyAids200068
48Recommendations for the care of oral involvement in patients with systemic sclerosisArthritis Care and Research201168
49Predictors at diagnosis of a first Wegener's granulomatosis relapse after obtaining complete remissionRheumatology201066
50Myopathies related to systemic sclerosis: a case–control study of associated clinical and immunological featuresScandinavian Journal of Rheumatology201064